High-density lipoprotein (HDL) with its cardio- protective effects has provided remarkable optimism to the ever-increasing incidences of coronary artery disease. Therefore, the aim of this randomized, comparative, research trial was to determine whether endurance exercise training, weight training and/or a combination of aerobic and weight training can be utilized in the management of high-density lipoprotein cholesterol (HDL-C). Subsequent to the 16-week intervention period, dependant t-Tests revealed that the non-exercising and weight training groups demonstrated non- significant mean 1.3% (p = 0.754) and 11.1% (p = 0.069) increases in fasting serum HDL-C, respectively. Conversely, there was a significant increase in HDL-C following the 16 weeks of endurance training (p = 0.003) and combination training (p = 0.005) (22.4% and 37.9%, respectively). Further, Spearman’s rho indicated no correlations between HDL-C and BMI (r = -0.131), percentage body fat (r = - 0.141), cholesterol intake (r = - 0.026) and total fat intake (r = - 0.239). The absence of changes in these inter-correlations indicated that changes in these parameters had no effect on the HDL-C. On the contrary, moderate correlations were established between HDL-C and number of cigarettes smoked daily (r = - 0.344) and intake of saturated fat (r = - 0.317) indicating that exercise effect on these variables could have indirectly contributed significantly in altering HDL- C in the endurance and combination training groups. As such, endurance and combination training can be utilized as an effective method in the management of HDL-C in sedentary male smokers.

The high density lipoprotein (HDL) receptor Scavenger Receptor, Class B, Type I (SRBI) is a 509 amino acid integral membrane protein which has been shown to have an important role in HDL-mediated reverse cholesterol transport. SR-BI has been shown to mediate selective uptake of cholesterol, and also mediates efflux of cholesterol to HDL as seen in in vitro cell culture studies. SR-BI is abundant in the liver and steroidogenic tissues, and is also present in macrophages, which play an important role in the initial stages of atherosclerotic development. SR-BI has been shown to be protective against atherosclerosis by way of overexpression and knockout (KO) studies in murine atherosclerosis models, including low density lipoprotein receptor (LDLR) knockout mice, apolipoprotein E (ApoE) knockout mice, and human apolipoprotein B (ApoB) transgenic mice. SR-BI/LDLR double knockout (dKO) mice show a 6-fold increase in diet-induced atherosclerosis compared to LDLR single KO controls, and SR-BI/ApoE dKO mice show severe coronary occlusion, myocardial infarction, and premature death on a normal chow diet. In both, plasma total cholesterol levels are significantly elevated, and associated with abnormally large HDL particles. The majority ofSR-BI's atheroprotective effect has been shown to result from plasma cholesterol clearance by way of selective uptake in the liver. Recently, Covey et al showed that elimination of SRBI expression in macrophages of LDLR KO mice resulted in increased diet-induced atherosclerosis. To see if SR-BI in macrophages contributes to the overall atheroprotective effect of SR-BI in ApoE KO mice, presumably by mediating cellular cholesterol efflux to HDL, selective deletion ofSR-BI was induced in bone marrow derived cells of ApoE KO mice using bone marrow transplantation. Female ApoE -/recipient mice were transplanted with either SR-BI +/+ ApoE -/-or SR-BI -/- ApoE -/bone marrow from male donor mice, and fed a high fat diet for 12 weeks. This resulted in significantly increased atherosclerosis in mice transplanted with SR-BI -/- ApoE -/-bone marrow, with a concomitant decrease in cholesterol associated with HDL-sized lipoproteins. No significant differences were seen in plasma total cholesterol levels or levels of cholesterol associated with non-HDL lipoproteins. These data suggest that SRBI in macrophages contributes to SR-BI's overall protective effect against atherosclerosis, and also plays a role in the regulation ofHDL cholesterol, in ApoE deficient mice. / Thesis / Master of Science (MSc)

Πρόσφατα δεδομένα σε πειραματικά μοντέλα ζώων αλλά και σε ασθενείς καταδεικνύουν την σημαντικότητα της «ποιότητας» της λιποπρωτεΐνης υψηλής πυκνότητας (HDL), σε σχέση με την ποσότητά της, στην προστασία από τη στεφανιαία νόσο. Τα κύρια χαρακτηριστικά της HDL τα οποία καθορίζουν την «ποιότητά» της, είναι η ανάστροφη μεταφορά χοληστερόλης, οι αντιοξειδωτικές και αντιφλεγμονώδεις ιδιότητές της καθώς επίσης και η ικανότητά της να προάγει την παραγωγή ΝΟ στο αρτηριακό επιθήλιο και να ρυθμίζει την ομοιόσταση της γλυκόζης αίματος. Στην συγκεκριμένη ερευνητική εργασία μελετάμε την επίδραση που έχει η ενεργοποίηση του φαιού λιπώδους ιστού, μέσω της έκθεσης φυσιολογικών πειραματικών μοντέλων μυών, σε περιβάλλον χαμηλής θερμοκρασίας, στο λιπιδαιμικό προφίλ, καθώς και στην λειτουργικότητα της HDL. Είναι γνωστό είναι ότι η ενεργοποίηση του φαιού λιπώδους ιστού, λόγω έκθεσης πειραματόζωων σε περιβάλλον χαμηλής θερμοκρασίας, οδηγεί σε θερμογένεση, κάθαρση των τριγλυκεριδίων από το αίμα παχύσαρκων ποντικών, μείωση του βάρους τους, έλεγχο του καταβολισμού των λιποπρωτεϊνών και ομαλοποίηση της ανοχής τους στην γλυκόζη. Έτσι θελήσαμε να επεκτείνουμε την μελέτη μας, στον ενδεχόμενο ρόλο του εγκλιματισμού των πειραματόζωων μετά από μακρόχρονη έκθεσή τους στο ψύχος στους παραπάνω παράγοντες. Για την επίτευξη των πειραματικών μας στόχων δημιουργήθηκαν τρεις ομάδες C57BL/6 μυών εκ των οποίων η μια εκτέθηκε σε περιβάλλον χαμηλής θερμοκρασίας για 2 εβδομάδες (βραχύχρονη έκθεση στο ψύχος), η άλλη ομάδα για 12 εβδομάδες (μακρόχρονη έκθεση στο ψύχος), ενώ η τρίτη αποτέλεσε την ομάδα ελέγχου. Στις δύο ομάδες μυών έγιναν κινητικές μελέτες έκκρισης και κάθαρσης τριγλυκεριδίων. Επίσης απομονώθηκαν από το πλάσμα του αίματος, τα λιποπρωτεϊνικά κλάσματα στα οποία έγιναν αναλύσεις για τον έλεγχο της ποσότητας και της ποιότητας της HDL. Τα αποτελέσματά μας καταδεικνύουν την επαγωγή θερμογένεσης από τον φαιό λιπώδη ιστό και στις δύο πειραματικές ομάδες, με αυτή να είναι πιο έντονη κατά την βραχύχρονη έκθεση στο ψύχος. Παρόλο που η κατανάλωση τροφής στις ομάδες που εκτέθηκαν στο ψύχος αυξήθηκε, το σωματικό τους βάρος παρέμεινε το ίδιο, μιας και η περίσσεια διατροφικών λιπιδίων χρησιμοποιούνταν από τον φαιό λιπώδη ιστό για την παραγωγή θερμότητας παρά για αποθήκευσή τους στον λευκό λιπώδη ιστό. Η εντερική απορρόφηση τριγλυκεριδίων αυξήθηκε σε σχέση με την ομάδα ελέγχου καθώς πιθανά ο οργανισμός χρειαζόταν τα λιπίδια για θερμογένεση, ενώ η ηπατική έκκριση τριγλυκεριδίων μειώθηκε. Η ολική χοληστερόλη των λιποπρωτεϊνικών κλασμάτων, στις πειραματικές ομάδες, έτεινε να βρίσκεται συγκεντρωμένη στα πιο ώριμα κλάσματα, ιδιαίτερα έπειτα από μακρόχρονη έκθεση στο πειραματικό περιβάλλον. Επιπλέον η HDL την 12η εβδομάδα, παρουσίασε καλύτερη αντιοξειδωτική δράση καθώς και διατήρησε αμιγή την ικανότητα να επιτελεί εκροή χοληστερόλης από τα κύτταρα. Τα ευρήματά μας οδηγούν σε δύο ενδιαφέρουσες ανακαλύψεις: 1) Η βραχεία έκθεση στο ψύχος έχει μεγαλύτερη επίδραση στη θερμογένεση και την παραγωγή ATP, απ’ ότι η μακρά έκθεση. 2) Η μακρά έκθεση στο ψύχος οδηγεί σε πιο λειτουργική HDL σε σχέση με την ομάδα βραχείας έκθεσης. Κατά συνέπεια τα αποτελέσματα μας αυτά, καταδεικνύουν εγκλιματισμό των πειραματόζωων στο ψύχος, ο οποίος συνοδεύεται από ποιοτικότερη και πιο λειτουργική HDL. / Recent data indicate the significance of “HDL quality” in atherosclerosis, rather than HDL cholesterol levels in plasma, suggesting that composition as well as functionality of HDL particle, imparts the atheroprotective property of HDL. The main atheroprotective property of HDL is cholesterol efflux in addition to anti-inflammatory and antioxidant properties. HDL has also the ability to promote NO production in the arterial lining and to regulate blood glucose levels. In this study we intend to examine whether brown adipose tissue activation, through low environmental temperature, affects lipid profile and functionality of HDL in C57BL/6 mice. Previous studies have shown that BAT is activated in animals which have been exposed to low temperature environment, resulting in thermogenesis, blood triglycerides clearance, weight reduction, control of lipoproteins catabolism and normalization of glucose tolerance. Thus we intended to study the possible role of acclimatization after long-term exposure to cold temperature regarding the above factors. Therefore we formed three groups of C57BL/6 mice, one of which was exposed to 4oC environment for 2 weeks (short-term exposure), the other one for 12 weeks (long-term exposure) and the last one at 28oC environment (control group). Kinetic studies of triglyceride secretion and clearance where performed, to all groups of animals. Analyses regarding HDL quantity and quality, where performed in lipoprotein fractions isolated from plasma. Our data demonstrate the induction of thermogenesis in BAT in both experimental groups, which appeared to be more intense during the short-term exposure. Although food consumption, in groups exposed to cold, was increased, body weight did not change, as BAT used the excess dietary lipids in order to produce heat rather than storing them in white adipose tissue. Intestinal absorption of triglycerides was increased compared to the control group, possibly because lipids are needed due thermogenesis. Total cholesterol in HDL fractions, tended to be concentrated in more mature fragments, especially after long-term exposure. In addition HDL, during long-term exposure, showed to have more effective antioxidant potential and cholesterol efflux, compared to the group exposed to cold temperature for 2 weeks. Our observations lead to two interesting findings: 1) Short-term exposure to cold has greater effect on thermogenesis and ATP production rather than long-term exposure. 2) After long-term exposure to cold, HDL appears to be more functional compared to the short-term exposure group. Therefore our results indicate acclimation of the animals to low temperature environment, followed by a qualitative HDL.

Abstract The cholesteryl ester transfer protein (CETP) is a plasma protein that transfers cholesteryl esters and triglycerides between plasma lipoproteins. Humans with a genetic CETP deficiency have high plasma high density lipopoprotein cholesterol (HDL-C) levels, whereas the CETP transgene lowers plasma HDL-C levels in mice. The role of CETP in the development of atherosclerosis is unclear due to the controversial results of many human and animal studies. The present research was designed to investigate the CETP gene as a candidate gene in the regulation of plasma HDL-C levels and the development of atherosclerosis in humans. The CETP gene was screened for mutations and polymorphisms associated with these traits in a well-characterized, homogenous population sample of 515 men and women and in a sample of 115 men with low HDL-C levels and coronary heart disease (CHD). Using polymerase chain reaction and single-strand conformation polymorphism analysis (PCR-SSCP), three polymorphic sites were found (A373P, I405V, R451Q) in the exons of the CETP gene, one in intron 9 and one in the 3'untranslated region of the CETP gene. In addition, the genotypes of a functional promoter polymorphism were determined. The V405 allele was associated with lower plasma CETP activity in the whole population sample, and the Q451 allele and the P373 allele were associated with higher plasma CETP activity in men, whereas the genotypes of the promoter polymorphism were not significantly associated with plasma CETP activity. The genotypes of the CETP gene explained about 20 % of the variation of plasma CETP activity in men. The CETP gene polymorphisms were found to be a minor regulator of plasma HDL-C levels, and these associations interacted with alcohol consumption, sex and triglyceride levels. The strongest association was detected between the promoter polymorphism and HDL-C levels in women. The variation at the CETP gene locus explained about 8 % of the variation in plasma HDL-C levels in women, but less than 1 % in men. CETP gene polymorphisms (A373P, I405V and R451Q) were associated with carotid intima-media thickness, explaining about 6 % of the variation in men and 4 % in women. However, none of the polymorphisms were associated significantly with the CHD risk. In conclusion, the CETP gene was found to be polymorphic and a minor regulator of plasma HDL-C levels and the development of atherosclerosis.

Magister Pharmaceuticae - MPharm / Cardiovascular diseases (CVDs) such as ischaemic heart diseases, heart failure and stroke remain a major cause of death globally. Various deep-rooted factors influence CVD development; these include but are not limited to elevated blood lipids, high blood pressure, obesity and diabetes. A considerable number of proteins are involved directly and indirectly in the transport, maintenance and elimination of plasma lipids, including high and low-density lipoprotein cholesterol (HDL-C and LDL-C). There are several mechanisms involved in the removal of LDL particles from systemic circulation. One such mechanism is associated with the gene that encodes proprotein convertase subtilisin/kexin type 9 (PCSK9), which has become an exciting therapeutic target for the reduction of residual risk of CVDs. Currently, statins are the mainstay treatment to reduce LDL-C, and a need exists to further develop more effective LDL-C-lowering drugs that might supplement statins. This study was aimed at contributing to the generation of knowledge regarding the effect of niacin in reducing LDL levels through PCSK9 interaction.

No description available.

Prior studies of lipid and lipoprotein levels alterations associated with the administration of danazol, a testosterone derivative, in patients treated for endometriosis have been conflicting. We administered danazol to 7 normal menstruating women and measured plasma lipid and lipoprotein cholesterol levels prior to and 2 months after treatment. Small, non-significant decreases in total plasma cholesterol and triglyceride levels were seen, largely due to a dramatic decline in one woman with type IV hyperlipoproteinemia. No significant change in low density or very low density lipoprotein cholesterol levels was seen. However, a marked (40%) reduction of high density lipoprotein cholesterol level in the mean was found. These findings have implications for the atherogenic potential of danazol, the treatment of hyperlipidemia, and the relationship between gonadal hormones and lipoprotein levels.

No description available.

No description available.

No description available.